A phase I trial of intracranial dendritic cell immunotherapy for patients with malignant glioma

被引：0
|
作者：
Yu, John S.
Liu, Gentao
Ng, Hiushan
Wagenberg, Mia
Luptrawan, Anne
Mindlin, Elina
Wheeler, Christopher J.
Black, Keith L.
机构：
来源：
NEUROSURGERY | 2006年 / 59卷 / 02期
关键词：
D O I：
10.1227/00006123-200608000-00132
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：485 / 486
页数：2
相关论文
共 50 条
  • [1] Dendritic cell-based immunotherapy for patients with malignant glioma
    Chernykh, E.
    Stupak, V.
    Leplina, O.
    Shevela, E.
    Pendurin, I.
    Nikonov, S.
    Ostanin, A.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S161 - S161
  • [2] Adjuvant autologous dendritic cell immunotherapy for malignant gliomas: A phase I and II clinical trial
    Cho, Der-Yang
    Yang, Wen-Kang
    Lee, Hang-Chung
    Lin, Hong-Lin
    Liln, Shinn-Long
    Ho, Li-Hwei
    NEUROSURGERY, 2008, 62 (06) : 1426 - 1426
  • [3] A Phase I Trial of Tumor Associated Antigen-pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
    Phuphanich, Surasek
    Chu, Ray M.
    Rudnick, Jeremy
    Mamelak, Adam
    Mazer, Mla
    Wang, Hong Q.
    Luptrawan, Anne
    Brian, Suzane
    Francisco, Marites
    Serrano, Natalia
    Yu, John S.
    Singh, Manish
    Wheeler, Christopher J.
    JOURNAL OF IMMUNOTHERAPY, 2008, 31 (09) : 938 - 938
  • [4] Cellular immunity of patients with malignant glioma:: prerequisites for dendritic cell vaccination immunotherapy
    Rapp, Marion
    Oezcan, Zakir
    Steiger, Hans-Jakob
    Wernet, Peter
    Sabel, Michael C.
    Sorg, Rudiger V.
    JOURNAL OF NEUROSURGERY, 2006, 105 (01) : 41 - 50
  • [5] A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma
    Phuphanich, S.
    Rudnick, J.
    Chu, R.
    Mazer, M.
    Wang, H.
    Serrano, N.
    Francisco, M.
    Wheeler, C.
    Singh, M.
    Yu, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
    Yasuharu Akasaki
    Tetsuro Kikuchi
    Sadamu Homma
    Shigeo Koido
    Toshifumi Ohkusa
    Tetsunori Tasaki
    Kazumi Hayashi
    Hideo Komita
    Nobuyuki Watanabe
    Yuta Suzuki
    Yohei Yamamoto
    Ryosuke Mori
    Takao Arai
    Toshihide Tanaka
    Tatsuhiro Joki
    Takaaki Yanagisawa
    Yuichi Murayama
    Cancer Immunology, Immunotherapy, 2016, 65 : 1499 - 1509
  • [7] A PHASE I TRIAL OF TUMOR-ASSOCIATED ANTIGEN-PULSED DENDRITIC CELL IMMUNOTHERAPY FOR PATIENTS WITH BRAIN STEM GLIOMA AND GLIOBLASTOMA
    Phuphanich, Surasak
    Mamelak, Adam
    Rudnick, Jeremy
    Chu, Ray
    Luptrawan, Anne
    Brian, Suzane
    Mazer, Mia
    Wang, Hong Qiang
    Xu, Minlin
    Serrano, Natalia
    Francisco, Marites
    Singh, Maniah
    Wheeler, Christopher
    NEURO-ONCOLOGY, 2008, 10 (05) : 815 - 816
  • [8] Phase I/II trial of combination of temozolomide chemotherapy and immunotherapy with fusions of dendritic and glioma cells in patients with glioblastoma
    Akasaki, Yasuharu
    Kikuchi, Tetsuro
    Homma, Sadamu
    Koido, Shigeo
    Ohkusa, Toshifumi
    Tasaki, Tetsunori
    Hayashi, Kazumi
    Komita, Hideo
    Watanabe, Nobuyuki
    Suzuki, Yuta
    Yamamoto, Yohei
    Mori, Ryosuke
    Arai, Takao
    Tanaka, Toshihide
    Joki, Tatsuhiro
    Yanagisawa, Takaaki
    Murayama, Yuichi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (12) : 1499 - 1509
  • [9] Phase I/II Trial of Combination of Temozolomide Chemotherapy and Immunotherapy With Fusions of Dendritic and Glioma Cells in Patients With Glioblastoma
    Kim, Wi Jin
    Newman, W. Christopher
    Amankulor, Nduka M.
    NEUROSURGERY, 2017, 81 (01) : N11 - N11
  • [10] A phase I/II trial of vandetanib for patients with recurrent malignant glioma
    Kreisl, Teri N.
    McNeill, Katharine A.
    Sul, Joohee
    Iwamoto, Fabio M.
    Shih, Joanna
    Fine, Howard A.
    NEURO-ONCOLOGY, 2012, 14 (12) : 1519 - 1526
12345